Document jmBX62qZmneV7KBJzkwEGp13y
OCT 2 9 19-4
THE DOW CHEMICAL COMPANY
October 25, 1974
BENNETT BUILDING 2030 DOW CENTER MIDLAND. MICHIGAN 48640
Mr. K. D. Johnson
Manufacturing Chemists' Assoc.
1825 Connecticut Ave., N.W.
Washington, D.C.
20009
Mr. H. L. Kusnetz
Shell Oil Company
Room 1574, One Shell
Houston, TX
77002
Plaza
Three protocols are attached. The first summarizes briefly the current study at IBT. The second summarizes the study the committee developed Sept. 18, 1974 and which it agreed should be discussed with the Rail Committee. The third is a proposal I put together since I don't like proposal #2.
I see no reason to omit hamsters and I would like to delay the start of more mice until we have metabolic data. My proposal accomplishes both.
I'll be calling you next week.
Sincerely,
ct 9. ^cdeddmd
Theodore R. Torkelson Corporate Medical Department
kjf
end.
CMA 001470
C':'I?
MANUiWJTURX
ASSOCIATION, INC.
CHRONIC VAPOR INHALATION TOXJ.CHTi' STUDY WITH VINYL CHLORIDE
IaDUSTRIAL B10-TEST L v ,0PAT0Pi2S DECATUR, ILLINOIS
I. Outline of Invest i gat ion
A. Typa and Lei.UthJ_
9-month vapor inhalation ir.
White Mice + S months observa-. Lon lz~nonLh vapor inhaJanion in
Albino Rats + 12 months obscr'-v.-ti'jn 12-month vapor inhalation ir.
Hamsters + 12 months observation.
B. Number f. An in'-'' is :
800 Mice. 900 Robs. 800 H:.V.~
C. ExtJO^ u : W r-nuie :
i .-.,i ii(;iivn per nv_ Five days per week.
D. Tost M itcr le.J.ii:
Vinyl Chloride (Ethylene doth-... :
E. Organlza ~ici::
a y p] )Xe 1
F. Dose Leveinp
See Table I.
G. Exposures Stortap: ` ExpQ3ures~~Urrnlr\vj-d
Terml r,1 Aut.oo sy :
Sept, ll ?.'2 7 mice, rats 1 hams torn J ui: c 19 7 4; mi c a. Sept. 1974; rats & hamsters. March 1975; mic e *. Sept. 1975; rats & hamsters.
C0II7IP3ITTIAL
Subject to Protective Order In Kqs3 v. Conoco, Inc., Do. 90-4837
14th Judicial District Court Calcasieu Parish,, Louisiana .
NOTE: Excess mortality made it necessary to sacrifice all TL'-IT and TE-JIl n:ce alter ii months on ey;.v;,; i.p.ent.
-I-
CMA 001471
itst "aterial
'. .1, '.*1
Vinyl Chloride {Ethylene derived)
TABLE I CHRONIC VAPOR INHALATION TOXICITY STUDY
Organization of Groups
Group
f/.ica Males Females
Number of Animals
Rats
Hamsters
Males Females Males Female
Control
100
100
100*
100*
100
100
TS-I
Low Level 50 ppm
too
TE-II
Intermediate Level - 100 200 ppm
T2-III High Level 2500 ppm
LOO
T3-IV
High Level 2500 ppm with food
-
100 ICO 100
-
100* 100* 100*
-
100* 100* 100* 100
100 100 100
-
100 100 100
-
f'Saoh of these rat groups were reduced by sacrifice ^f 5 rats for cytogentic and histopathological 2xam ^nation at the end of-.the 12 th month of exposure.
CMA 0 0 1 4 7 2
v:" ...
--r.:,Trr,R cirflor m
ect to Pv0^" ilo. 90-4837`
Ross v.-^cnor:o_.--Court
04tb Xudxclul^^ I(0al6lana
XI. Chamber Parameters
Each group of animals will be exposed in a specially
constructed stainless steel and plexiglass inhalation
chamber having a capacity of approximately 9.3
allowing
animal loading of less than 2% when the animals reach
maturity. Flow rate through the chamber will be at least 3
1.53 M /min. providing a theoretical air change every
six minutes. The chamber supply air will be filtered
and maintained at 40% to 60% relative humidity and 70 to 75F. Food will be removed frr all animal cages
during exposure except Group TE IV rats.
. -T*
III. Animal Parameters A. Clinics 1 Observations
'....`-.S'.
C--'r'Vn sti-sia.n3-
14 J' ^ a\l i'i" calc-B
All animals will be observed daily for lesions and behavioral changes attributable to the test material. The time of appearance and location of all tumors that occur among both control and test animals will be recorded. Mortality records will be kept on all groups of animals. All animals which die during the study will be necropsied and their tissues processed in accordance with the methods given in the Anatomic Pathology Section. Care will be exercised to minimize loss of tissues through cannibalism or autolysis. Animals in a moribund state will be sacrificed in extremis when death is imminent.
B. Body Weights
Individual body weights will be recorded once before exposure and after 1, 2, 3, and 4 weeks of testing.
-3-
CMA 001473
Thereafter, mei:n group body 'weights v/ill be determined monthly up to the 12-month point of study.
C. Clinioai Pachology
Hemoglobin, hematocrit, total erylhrocyte and total leukocyte counts will be performed at 18 and 24 months on 30 (15 male and 15 female),rats of the control and each test group. Differential leukocyte counts will be performed on all animals having high total leukocyte counts.
D. Anatomic Pntho1ocry
1. Methods of Sacrifice
c2
uo oCh U, o ***, I c
o i Kr5* r
r-t o a\
p-! o 1W-1*, u-
J. oo ii11
H'r*<l
SEii o 9 i 't-'i
Oj-p 5 j ^
Upon completion of the study, all survivors will be sacrificed by exsanguination following carbon dioxide anesthesia.
2. Gross Pathology
Complete necropsies will be performed on all animals which die or are sacrificed and all macroscopic lesions will be recorded. The lungs will be inflated with formalin fixative.
3. Histopathology
Representative specimens of the following organs and tissues will be taken from all animals at time of sacrifice and fixed in 10.0% neutral buffered formalin:
-4-
CMA 001474
Pi^r' c if
oT^-ve Order in
- * "J "
no. 50-4337
14th Jvuiviil Calc'Siou ?ur
tv; 3 jr-ict Court 'sh,, Louisiana
Adrenal Glands All Gross Lesions Bone (femur, tarsal and metatarsal, including
long bones of all four limbs) Bone Marrow (sternal) Brain Both Ears (external auditory canal with ceruminal
(Zymbal's) glands) Esophagus Eye Gonads (testes and ovaries) Kidneys Large Intestine (caecum and colon) Liver Lungs Lymph Nodes (tracheobronchial, cervical and
mesenteric) Optic Nerve Pancreas Parathyroid Gland Pituitary Gland Prostate Salivary Gland
_j Gl _7!_ V ^W- O l_l_ *--< _l_ _.J Skin Small Intestine (duodenum, jejunum and ileum) Spleen Stomach Thymus Thyroid Gland Tracheo Urinary Bladder Uterus
The above tissues, from animals of the control,
TE-II, and TE-III will be processed by conventional
methods, embedded in paraplast, sectioned (4-6 p),
stained with hematoxylin and eosin, and evaluated
by light microscopy. If drug-related lesions are
detected in tissues from the high or intermediate
dose (TE-II or TE-III) animals, affected tissues
from the TE-I group animals will be processed and
examined in the same manner as the above.
-5-
CMA 001475
Only major organa (liver, kidney, spleen, heart, lungs) ana neoplasms from animals which die and are found in an advanced state of autolysis will be processed for histopathological evaluation.
IV. Reports
Quarterly summaries of mortalities, clinical observations, clinicopathologic and anatomopathologic findings will be prepared. Upon completion of the study, a complete report will be prepared and issued.
October 23, 1974
H CD V
.H ' 1 S :1s S-
o oo .of* ^ h u- dh -
I o f"iAl-rti W
r; Hi
b
-I'd o\ P*
P*. o\.
o o
iO r
if) \ wiS
^
oo # wl
co
sC0iV3r
u
a
-6-
CMA 001476
PROPOSED PROTOCOL A
MANUFACTURING CHEMISTS' ASSOCIATION, INC.
CHRONIC VAPOR INHALATION TOXICITY STUDY WITH VINYL CHLORIDE
Outline of Investigation
A. Type and Length*:
9-month vapor inhalation exposure in White Mice plus 9 months observation. 12-month vapor inhalation in Albino Rats plus 12 months observation.
B. Number of Animals:
500 Mice 500 Rats
C. Exposure Duration:
Seven hours per day. Five days per week.
D. Test Materials:
Vinyl Chloride
E. Organization:
See Table I
F. Dose Levels:
See Table I
G. Proposed Schedule:
Terminal
Group
Exposures Start Exposures Stop Autopsy
Mice: Control, I-, II, III
Dec. 1974
Sept. 1975
June 1976
Rats: Control, I, II, III
Dec. 1974
Dec. 1975 t
Dec. 1976
1- -
r;OIi?IDSlTTIAL\ _ ' v;
Subject to Protective Order lit -S v. Conoco. Ino. No.; 90r4833 =55*i> Judicial District' Court
CilOMlou Parish,, Louisiana
CMA 001477
TABLE I CHRONIC VAPOR INHALATION TOXICITY STUDY VINYL CHLORIDE
. Organization of Groups
Group
Control
I II III
Low Level 1.5 ppm
Intermediate Level 5 ppm
High Level 15 ppm
Number of Animals
Mice
Rats
Males Females
Males Females
125 125 125 125
125 125 125 125
125 125 125 125
125 125 125 125
Total
500
500
500
500
30HPI3)EHTIAL\
to Protective Order'll! n Conoco, Ino., No. 90-482%
fndiciJtl Diotrict Court
eibu Pjtrish, Loulaiana
2- -
001478
__ ----srmT ,\li
SiSJert
so- 90'4f
II. Chamber Parameters
Each group of animals will be exposed in a specially
constructed stainless steel and plexiglass inhalation 3
chamber having a capacity of approximately 9.3 M ,
allowing animal loading of less than 3% by volume when
the animals reach maturity. Flow rate through the. 3
chamber will be at least 1.53 M /min. providing a
theoretical air change every six minutes. The chamber
supply air will be filtered and maintained at 40% to 60% relati;Te humidity and 70 to 75F. Mice are to be
individually caged; rats will be caged in groups. and water will be provided ad libitum.
Food
III. Animal Parameters
A. Clinical Observations:
All animals will be observed daily for lesions and behavioral changes attributable tc the test material. The time of appearance and location of all tumors that occur among both control and test animals will be recorded. Mortality records will be kept on all groups of animals. All animals which die during the study will be necropsied and their tissues processed in accordance with the methods given in the Anatomic Pathology Section. Care will be exercised to minimize loss of tissues through cannibalism or autolysis. Animals in a moribund state will be sacrificed in extremis when death is imminent.
-3-
CMA 001479
B. Body Weightr.
Individual body weights will be recorded once before exposure and after 1, 2, 3, and 4 weeks of testing. Thereafter, mean group body weights will be determined monthly up to the 12-month point of the study.
C. Clinioal Pathology
Hemoglobin, hematocrit, total erythrocyte and total leukocyte counts will be performed at 18 and 24 months on 30 (15 male and 15 female} rats of the control and each test group. Differential leukocyte counts will be performed on all animals having high total leukccycc counts.
D. Anatomic Pathology
1, Methods of Sacrifice
Upon completion of the study, all survivors will be sacrificed by ersanguinaticn following carbon dioxide anesthesia.
Gross Pathology
Complete necropsies will be performed' on all animals which die or are sacrificed and all macroscopic lesions will be recorded. The lungs will be inflated with formalin fixative.
CMA 001480
Histopatho1oay
""STIAL `to Pi.utscbivs Order Int Pc53 7. Conoco , Ino. No ,i 90 t:4832 Judioisil" District Court'" Calonsisu F arist,, Louisiana; '
Representative specimens of tec following organs and tissues will be. taken from all animals at time of sacrifice and fixed in 10.05 neutral buffered formalin:
Adrenal Glands All Gross Lesions Bone (femur, tarsal and metatarsal, -including
long bones of all four limbs) Bone Marrow (sternal) Brain Both Eyes (external auditory canal with ceruminal
(Zymbal1s} glands) Esophagus Eye Gonads (testes and ovaries) Kidneys Large Intestine (caecum and colon) Liver Lungs Lymph Nodes (tracheobronchial, cervical and
tpri t? r* }- *'** r* \
Optic Nerve Pancreas Parathyroid Gland Pituitary Gland Prostate Salivary Gland Seminal Vesicles Skin Small Intestine (duodenum, Spleen Stomach Thymus Thyroid Gland Tracheo Urinary Bladder Uterus
jejunum and ileum)
The above tissues, from all animals, will be processed by conventional methods, embedded in paraplast, sectioned (4-6 p), stained with hematoxyline and eosin, and evaluated by light microscopy.
-5-
CMA. 001481
IV.
Only major organs (liver, kidney, spleen, heart, lungs) and neoplasms from animals which die and are found in an advanced state of autolysis will be processed for histopathologic evaluation.
Reports
Quarterly summaries of mortalities, clinical observations, clinicopathologic and anatcmopathologic findings will be prepared. Upon completion of the study, a complete report will be prepared and issued.
October 23, 1974
-6-
h0 o ID
vA> \V* O vo 2O
Tij
&\.-
P'br"1\\.'fo. 0
o\3* |Vsu
\ O C ' rtf
O'
o V$ o
CMA 001482
PROPOSED PROTOCOL B
:\ib"''" C "i;o 90-^8371 P053-V- Ccrio^^.- Court' -^th JudWli^st-10,1,alana-
Calcasiau Pax--^'
MANUFACTURING CHEMISTS' ASSOCIATION, INC. CHRONIC VAPOR INHALATION TOXICITY STUDY WITH VINYL CHLORIDE
I. Outline of Investigation
A. Type and Length*;
6-month vapor inhalation in Albino rats plus 18 months observation. 12-month vapor inhalation in Albino Rats plus 12 months observation. 12-month vapor inhalation in Hamsters plus 12 months observation. 9-month vapor inhalation in White Mice plus 9 months observation.
B. Number of Animals:
1400 Rats 800 Hamsters 800 Mice
C. Exposure Duration: D. Test Materials:
Seven hours per day. Five days per week.
Vinyl Chloride
._
E. Organization:
See Table I.
F. G. Group
Dose Levels: Proposed Schedule:
See Table I.
!
Exposures Start Exposures Stop
Terminal Autopsy
Rats: Control, 1-6, II-6, III-6, 1-12, 11-12, III-12
Dec. 1974 Dec. 1974
June 1975 Dec. 1975
Dec. 1976 Dec. 1976
Hamsters: HI-12
1-12, 11-12,
Mice: 1-9, II-9, III-9
Dec. 1974 June 1975
Dec. 1975 Mar. 1976
Dec. 1976 Dec. 1976
CMA 001483
TABLE I
CHRONIC VAPOR INHALATION TOXICITY STUDY VINYL CHLORIDE
Proposal B Organization of Groups
X
II III 1-6 II-6 III-6
Group
Number of Animals
Rats
Hamsters
Males Females Males Females
Mice Males Females
Control
Low Level 1.5 ppm
100 100
100 100
100 100
100 100
100 100
100 100
Intermediate Level - 100 5 ppm
100
100
100
100
100
High Level 15 ppm
100
100
100
100
100
100
Low Level 1.5 ppm
100
100
Intermediate Level - 100 5 ppm
100
High Level 15 ppm
100
100
TOTAL
700
700
400
400
400
400
CMA 001484
- 0 Oli r ~ v
_
Subject to
Ko. 90-4837.
?oss v. Ccno2j--rr-T". _v Court
Chamber Parameter
Each group of animals will be exposed in a specially construe
stainless steel and plexiglass inhalation chamber having a capacity of approximately 9.2 M3 , allowing animal loading of
less than 2% by volume when the animals reach maturity. 3
Flow rate through the chamber will be at least 1.53 M /rain,
providing a theoretical air change every six minutes. The
chamber supply air will be filtered and maintained at 40% to 6C% relative humidity and 70 to 75F. Mice are to be
individually caged; rats will bo caged in groups. water will be provided <_u_ libitum.-
Food and
All rats and hamsters will be started simultaneously. After 6 months of exposure groups TE-I-6, TE-II-6 and TE-III-6 will be removed from exposure and kept for 18 months observation. The exposures of the mice will then commence. Therefore, all terminal autopsies will take place simultaneously 24 months after the start of the experiment.
Animal Parameters
A. Clinical Observations:
All animals will be observed daily for lesions and behavioral changes attributable to the test material. The time of appearance and location of all tumors that occur among both control and test animals will be recorded. Mortality records will be kept on all groups of animals. All animals which die during the study will be necropsied and their tissues processed in accordance with the methods given in the Anatomic Pathology Section. Care will be exercised to minimize loss of tissues through cannibalism or autolysis. Animals in a moribund state will be sacrificed in extremis when death is imminent.
CMA 001485
B. Body Weights
Individual body weights will bo recorded once before exposure and after 1, 2, 3, and' 4 weeks of testing. Thereafter, mean group body weights will be determined monthly up to the 12-mcnth point of the study.
C. Clinica.l Pathology
Hemoglobin, hematocrit, total erythrocyte and total leukocyte counts will bo performed at 18 and 24 months on 30 (15 male and 15 female), rats of the control and each test group. Differential leukocyte counts will be performed on all animals having high total leukocyte counts.
D. Anatomic Pathology
t-
:I sCO JJ, ? t 1 2Q O O5 m * r! S2 o
A"hra
*
1-1 &
5 `g i'S5 -3
3 2 ^ CD tg
Pi
1. Methods of Sacrifice
Upon completion of the study, all survivors will be sacrificed by exsanguination following carbon dioxide anesthesia.
2. Gross Pathology
Complete necropsies will be performed on all animals which die or are sacrificed and all macroscopic lesions will be recorded. The lungs will be inflated with formalin fixative.
4- -
CMA 001486
Kisfcna-'holoav
1 XL
SQSsusbvje.ctCotonogPpr,otIencot.!,--2Kc-O.. r'JdCe-r48in37, I4th- JudloiTrF^ i"t Court
, Calctsieu Parisn, T: ouirtrrra
Representative spec.-mens of the following organs and tissues will be, taken from all animals at time of sacrifice and fixed in 10.OS neutral buffered formalin:
Adrenal Glands All Gross Lesions Bone (femur, tarsal arid metatarsal, including
long bones of all four liuibs) Bone Marrow (sternal) Brain Both Eves (external auditory canal with ceruminal
(Zymba.L's) glanus) Esophagus Eye Gonads (testes and ovaries) Kidneys Large Intestine (caecum and colon) Liver Lungs Lymph Nodes (tracheobronchial, cervical and
Optic Nerve Pancreas Parathyroid Gland Pituitary Gland Prostate Salivary Gland Seminal Vesicles Skin Small Intestine (duodenum, Spleen Stomach Thymus Thyroid Gland Tracheo Urinary Bladder Uterus
jejunum and ileum)
The above tissues, from all animals, will be processed by conventional methods, embedded in paraplast, sectioned (4-6 p) , stained with hematoxyline and eosin, and evaluated by light microscopy.
5-
CMA 001487
Only major organs (liver, kidney, spleen, heart, lungs) and neoplasms from animals which die and are found in an advanced stake of autolysis will be process ad for histopathologic evaluation.
IV.
Reports
Quarterly summaries of mortalities, clinical observations, clinicopathologic and anatomopatbologic findings will be prepared. Upon completion of the study, a complete' report will be prepared and issued.
October 23# 1974
-6-
ia v $
\ * A'!
4
ft cJ
CMA 001488
PROPOSED PROTOCOL A
MANUFACTURING CHEMISTS' ASSOCIATION, INC.
CHRONIC VAPOR INHALATION TOXICITY STUDY WITH VINYL CHLORIDE
Outline of Investigation
A. Type and Length*:
9-month vapor inhalation exposure in White Mice plus 9 months observation. 12-month vapor inhalation in Albino Rats plus 12 months observation.
B. Number of Animals:
500 Mice 500 Rats
C. Exposure Duration:
Seven hours per day. Five days per week.
D. Test Materials:
Vinyl Chloride
E. Organization:
See Table I
F. Dose Levels:
See Table I
G. Proposed Schedule:
Terminal
Group
Exposures Start Exposures Stop Autopsy
Mice: Control, t, II, III
Dec. 1974
Sept. 1975
June 1976
Rats: Control, If II, III
Dec. 1974
Dec. 1975
Dec. 1976
-1-
,n
Court - v n . T' `'
CMA 001489
TABLE I CHRONIC VAPOR INHALATION TOXICITY STUDY VINYL CHLORIDE
. Organization of Groups
Group
Control
I II III
Low Level 1.5 ppm
Intermediate Level 5 ppm
High Level 15 ppm
Number of Animals
Mice
Rats
Males Females
Males Females
125
125
125
125
125 125 125
125 125 125
125 125 125
125 125 125
T'otal
500
500
500
500
_
Q r7r?rotcctivc lOrder in
Sublet 1
ire . I'0 90-403*
let Court
I ' l II "
l, Louisiana
Calcasieu Parish,
-2-
t.
001490
II.
Chamber Parameters
C""1 _ *_ '-* r
r>
r
--- r z
_
--' '-".To^dsr
;r;':=o:so-w
court
f'jU x.(i'J.isi^T'-a
Each group of animals will bo exposed in a specially constructed stainless steel and plexiglass inhalation
3 chamber having a capacity of approximately 9.3 M , allowing animal loading of loss than ?.% by volume when the animals reach maturity. Flow rate through the
3 chamber will be at least 1.53 M /min. providing a theoretical air change every six minutes. The chamber supply air will be filtered and maintained at 40% to 60% relative humidity and 70 to 75F, Mice are to be
individually caged; rats will be caged in groups. and water will be provided ad libitum.
Food
III.
Animal Parameters
A. Clinical Observations:
All animals will be observed daily for lesions and behavioral changes attributable tc the test material. The time of appearance and location of all tumors that occur among both control and test animals will be recorded. Mortality records will be kept on all groups of animals. All animals which die during the study will be necropsied and their tissues processed in accordance with the methods given in the Anatomic Pathology Section. Care will be exercised to minimize loss of tissues through cannibalism or autolysis. Animals in a moribund state will be sacrificed in extremis when death is imminent.
-3-
CMA 001491
B. Body Weightn
Individual body weights will be recorded once before exposure and after 1, 2, 3, and 4 weeks of testing. Thereafter, mean group body weights will be determined monthly up to the 12-month point of the study.
C. Clinical Pathology
Hemoglobin, hematocrit, total erythrocyte and total leukocyte counts will be performed at 18 and 24 months on 30 (13 male and 15 female) rats of the control and each test group. Differential leukocyte counts will be performed on all animals having high total leukccycc counts.
D. Anatomic Pathology
CONFIDENTIAL
Subject, to rroxsotivs Order in iv Conoco, ins, , ITo. 90-4837,
1 o Methods of Sacrifice 14th Judicial District 'Court
Calcasieu Parish, Louisiana
Upon completion of the study, all survivors will be sacrificed by exsanguination following carbon dioxide anesthesia.
* 2.
Gross Pathology
Complete necropsies will be performed' on all animals which die or are sacrificed and all macroscopic lesions will be recorded. The lungs will be inflated with formalin fixative.
4- -
CMA 001492
Histopatholoqy
COi
Subject xo ^ <*\ *P <J ,, O 1
__ , j
*
urtr , - , ,.
Ca^sio,-J- -or^ri=;
Representative specimen? of the following organs and tissues will be taken from all animals at time of sacrifice and fixed in 10.0' neutral buffered formalin:
Adrenal Glands All Gross Lesions Bone (femur, tarsal and metatarsal, -including
long bones of all four limbs) Bone Marrow (sternal) Brain Bo til Eyes (external auditory canal with ceruminal
(Zymbal1s) glands) Esophagus Eye Gonads (testes and ovaries) Kidneys Large Intestine (caecum and colon) Liver Lungs Lymph Nodes (tracheobronchial, cervical and
4rkn*'-HftUf> fwjb.. 5u* W yv r-i \ Optic Nerve Pancreas Parathyroid Gland Pituitary Gland Prostate Salivary Gland Seminal Vesicles Skin Small Intestine (duodenum, jejunum and ileum) Spleen Stomach Thymus Thyroid Gland Tracheo Urinary Bladder Uterus
The above tissues, from all animals, will be processed by conventional methods, embedded in paraplast, sectioned (4-6 p), stained with hematoxyline and eosin, and evaluated by light microscopy.
-5-
CMA 001493
Only major organs (liver, kidney, spleen, heart, lungs) and neoplasms from animals which die and are found in an advanced state of autolysis will be processed for histopathologic evaluation.
IV.
Reports
Quarterly summaries of mortalities, clinical observations, clinicopathologic and anatcmopathologic findings will be prepared. Upon completion of the study, a complete report vill be prepared and issued.
October 23, 1974
,*
-6-
/
CMA 001494
PROPOSED PROTOCOL B MANUFACTURING CHEMISTS' ASSOCIATION, INC. CHRONIC VAPOR INHALATION TOXICITY STUDY WITH VINYL CHLORIDE
I. Outline of Investigation
A. Type and Length*;
6-month vapor inhalation in Albino rats plus 18 months observation.
12-month vapor inhalation in Albino Rats plus 12 months observation. 12-month vapor inhalation in Hamsters plus 12 months observation. 9-month vapor inhalation in White Mice plus 9 months observation.
B. Number of Animals:
1400 Rats 800 Hamsters 800 Mice
C. Exposure Duration:
Seven hours per day Five days per week.
D. Test Materials:
Vinyl Chloride
E. Organization:
See Table I.
F. Dose Levels:
See Table I.
G. Group
Proposed Schedule: Exposures Start
Exposures Stop
Terminal Autopsy
Rats: Control, 1-6, II-6, III-6, " 1-12, 11-12 , III-12
Hamsters: III-12
1-12, 11-12,
Mice: 1-9, II-9, III-9
Dec. 1974 Dec. 1974 Dec. 1974
June 1975
June 1975 Dec. 1975 Dec. 1975
Mar. 1976
Dec. 1976 Dec. 1976 Dec. 1976
Dec. 1976
CMA 001495
TABLE I
CHRONIC VAPOR INHALATION TOXICITY STUDY VINYL CHLORIDE
Proposal B Organization of Groups
X II III . 1-6 II-6 111-6
Group
Control
Low Level 1.5 ppm
Number of Animals
Rats
Hamsters
Males Females Males Females
Mice Males Females
100
100
100
100
100
100
100
100
100
100
100
100
Intermediate Level - 100 5 ppm
100
100
100
100
100
High Level 15 ppm
100
100
100
100
100
100
Low Level 1.5 ppm
100
100
Intermediate Level - 100 5 ppm
100
High Level 15 ppm
100
100
- ;o N^. 'n'* 5 \. v*
VVjK O\x V ^v
w
TOTAL
700 -2-
700
400
400
400
400
'CMA 0 0 1 4 9 6
v* ^
II.
Chamber Parameters
C03r?ID?*7T7 7 Hi"
***_. Cccoee
t 0rder Iff
*.NL4tH Jndi^TTrrr1
90'4837
'' .Calcastp?
-- '
'"Tt
Each group of animals will be exposed in a specially construe stainless steel and plexiglass inhalation chamber having a
3 capacity of approximately 9.2 M , allowing animal loading of less than 2% by volume when the animals reach maturity. Flow rate through the chamber will be at least 1.53 M /min.
providing a theoretical air change every six minutes. The chamber supply air will be filtered and maintained at 40% to 6C% relative humidity and 70 to 75F. Mice are. to be
individually caged; rats will be caged in groups. water will be provided ou_ libitum..
Food and
All rats and hamsters will be started simultaneously. After 6 months of exposure groups TE-I-6, TE-II-6 and TE-III-6 will be removed from exposure and kept for 10 months observation. The exposures of the mice will then commence. Therefore, all terminal autopsies will take place simultaneously 24 months after the start of the experiment.
III. Animal Parameters
A. Clinica1 Observations:
All animals will be observed daily for lesions and behavioral changes attributable to the test material. The time of appearance and location of all tumors that occur among both control and test animals will be recorded. Mortality records will be kept on all groups of animals. All animals which die during the study will be necropsied and their tissues processed in accordance with the methods given in the Anatomic Pathology Section. Care will be exercised to minimize loss of tissues through cannibalism or autolysis. Animals in a moribund state will be sacrificed in_ extremis when death is imminent.
CMA 001497
B. Body Weight5
Individual body vreights will be recorded once before exposure and after 1, 2, 3, and-4 weeks of testing. Thereafter, mean group body weights will be determined monthly up to the 12-mcnth point of the study.
C. Cl inic al Patho.log y
Hemoglobin, hematocrit, total erythrocyte and total leukocybe counts will bo performed at 18 and 24 months on 30 (15 male and 15 female), rats of the control and each test group. Differential leukocyte counts will be performed on all animals having high total leukocyte counts.
D. Anatomic Patholog
1. Methods of Sacrifice
Upon completion of the study, all survivors will be sacrificed by exsanguination following carbon dioxide anesthesia.
2. Gross Pathology
Complete necropsies will be performed on all animals which die or are sacrificed and all macroscopic lesions will be recorded. The lungs will be inflated with formalin fixative.
CMA 001498
3. Histern-holoav
" SuBJect to Protective Cr^er Ross V...C=noi0-^^-..^ rmtrt
Representative spec." mens of the following organs and tissues will be. taken from all animals at time of sacrifice and fixed in 10.0% neutral buffered formalin:
Adrenal Glands All Gross Lesions Bone (fs'mur, tarsal avid metatarsal, including
long bones of all four Hubs) Bono. Marrow (sternal) Brain Both Eyes (external auditory canal with ceruminal
(Zymbal's) glanus) Esophagus Eye Gonads (testes and ovaries) Kidneys Large Intestine (caecum and colon) Liver Lungs Lymph Nodes (tracheobronchial, cervical and
TT'9or.t`llv' *i r*' \ Optic Nerve Pancreas Parathyroid Glanc! Pituitary Gland Prostate Salivary Gland Seminal Vesicles Skin Small Intestine (duodenum, jejunum and ileum) Spleen Stomach Thymus Thyroid Gland Tracheo Urinary Bladder Uterus
The above tissues, from all animals, will be
processed by conventional methods, embedded in
paraplast, sectioned (4-6 p), stained with
hematoxyline and eosin, and evaluated by light
microscopy.
5
CMA 001499
Only major organs (liver, kidney, spleen, heart, lungs) and neoplasms from animals which die and are found in an advanced state of autolysis will be processed for histopathologic evaluation.
IV. Reports
Quarterly summaries of mortalities, clinical observations, clinicopathologic and anatomopathologic findings will be prepared. Upon completion of the study, a complete' report will be prepared and issued.
October 23, 1974
-6-
CMA 001500